Skip to main content

Table 2 Percentage of high expression of ER, PGR and Skp2 in the different histological subtypes N = 193

From: Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas

Histology

N

ER (%)*

PGR (%)**

Skp2 (%)***

Pleomorphic sarcoma

57

40

26

37

Leiomyosarcoma

47

50

43

40

Liposarcoma

32

35

23

21

MF/MFT

16

27

29

36

Angiosarcoma

8

25

13

29

Rhabdomyosarcoma

9

50

56

67

MPNST

9

11

11

44

Synovial sarcoma

12

40

27

50

Other STS

3

67

33

67

Total

193

39

30

38

  1. * Chi 8.516, p = 0.385.
  2. ** Chi 10.238, p = 0.249.
  3. *** Chi 8.596, p = 0.377.
  4. Abbreviations: MF/MFT, malignant fibroblastic/myofibroblastic tumors; MPNST, malignant peripheral nerve sheath tumor.
  5. Chi-square test showed no differences in percentage of high expression of ER, PGR and Skp2 in the different histological subtypes.